Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hospitals | 74 | 2021 | 3873 | 9.920 |
Why?
|
Quality of Health Care | 70 | 2020 | 4316 | 7.930 |
Why?
|
Medicare | 98 | 2024 | 6732 | 7.800 |
Why?
|
Hospital Administration | 23 | 2021 | 352 | 6.320 |
Why?
|
Patient Readmission | 47 | 2021 | 3249 | 6.050 |
Why?
|
Reimbursement, Incentive | 22 | 2020 | 540 | 5.550 |
Why?
|
Health Expenditures | 33 | 2023 | 2353 | 5.280 |
Why?
|
Quality Indicators, Health Care | 34 | 2021 | 1792 | 4.510 |
Why?
|
Electronic Health Records | 37 | 2021 | 4789 | 3.930 |
Why?
|
Hospital Mortality | 37 | 2021 | 5283 | 3.870 |
Why?
|
Diffusion of Innovation | 22 | 2021 | 726 | 3.640 |
Why?
|
Developed Countries | 11 | 2021 | 445 | 3.330 |
Why?
|
United States | 224 | 2024 | 72202 | 3.290 |
Why?
|
Fee-for-Service Plans | 23 | 2021 | 699 | 3.230 |
Why?
|
Quality Assurance, Health Care | 20 | 2018 | 2167 | 3.200 |
Why?
|
Health Care Costs | 23 | 2021 | 3240 | 2.820 |
Why?
|
Economics, Hospital | 12 | 2017 | 209 | 2.760 |
Why?
|
Patient Satisfaction | 17 | 2017 | 3457 | 2.710 |
Why?
|
Delivery of Health Care | 26 | 2024 | 5332 | 2.450 |
Why?
|
Medical Informatics | 10 | 2018 | 733 | 2.330 |
Why?
|
Hospitals, Veterans | 8 | 2016 | 395 | 2.260 |
Why?
|
Healthcare Disparities | 20 | 2021 | 3344 | 2.250 |
Why?
|
Efficiency, Organizational | 11 | 2015 | 695 | 2.180 |
Why?
|
Hospitals, Rural | 6 | 2020 | 174 | 2.160 |
Why?
|
Pneumonia | 23 | 2020 | 2140 | 2.130 |
Why?
|
Cost Savings | 13 | 2021 | 913 | 2.000 |
Why?
|
Hospitals, Teaching | 11 | 2023 | 1155 | 1.890 |
Why?
|
Surgical Procedures, Operative | 9 | 2021 | 1923 | 1.850 |
Why?
|
Medical Records Systems, Computerized | 16 | 2015 | 1191 | 1.790 |
Why?
|
Hospitalization | 29 | 2021 | 10698 | 1.750 |
Why?
|
Myocardial Infarction | 29 | 2020 | 11453 | 1.700 |
Why?
|
Health Care Reform | 9 | 2019 | 1245 | 1.620 |
Why?
|
Health Policy | 16 | 2022 | 2680 | 1.600 |
Why?
|
Humans | 349 | 2024 | 760437 | 1.580 |
Why?
|
Hospital Costs | 12 | 2019 | 948 | 1.560 |
Why?
|
Health Facility Merger | 3 | 2017 | 47 | 1.560 |
Why?
|
Heart Failure | 32 | 2021 | 11653 | 1.550 |
Why?
|
Hospital Bed Capacity | 13 | 2017 | 206 | 1.550 |
Why?
|
Health Services Accessibility | 21 | 2020 | 5421 | 1.530 |
Why?
|
American Recovery and Reinvestment Act | 7 | 2012 | 72 | 1.510 |
Why?
|
Patient Protection and Affordable Care Act | 16 | 2022 | 1185 | 1.480 |
Why?
|
Quality Improvement | 15 | 2021 | 3798 | 1.410 |
Why?
|
Hospitals, Voluntary | 3 | 2014 | 39 | 1.400 |
Why?
|
Patient Acceptance of Health Care | 7 | 2024 | 3190 | 1.310 |
Why?
|
Foreign Medical Graduates | 2 | 2021 | 77 | 1.280 |
Why?
|
Hospitalists | 5 | 2018 | 294 | 1.270 |
Why?
|
Climate Change | 4 | 2020 | 493 | 1.270 |
Why?
|
Public-Private Sector Partnerships | 2 | 2019 | 122 | 1.220 |
Why?
|
Insurance Coverage | 11 | 2022 | 1934 | 1.200 |
Why?
|
Hospitals, Community | 6 | 2023 | 365 | 1.190 |
Why?
|
Medical Record Linkage | 4 | 2011 | 285 | 1.180 |
Why?
|
Medicaid | 15 | 2020 | 2810 | 1.170 |
Why?
|
Insurance, Health, Reimbursement | 4 | 2019 | 385 | 1.170 |
Why?
|
Health Care Surveys | 19 | 2016 | 2425 | 1.160 |
Why?
|
Information Dissemination | 7 | 2019 | 1127 | 1.110 |
Why?
|
Aged | 108 | 2024 | 168840 | 1.090 |
Why?
|
Physicians | 12 | 2019 | 4586 | 1.080 |
Why?
|
Hospitals, Proprietary | 3 | 2015 | 39 | 1.070 |
Why?
|
Water Pollutants, Chemical | 4 | 2024 | 356 | 1.070 |
Why?
|
Mortality | 9 | 2020 | 2897 | 1.060 |
Why?
|
Cost Control | 4 | 2017 | 628 | 1.050 |
Why?
|
Accreditation | 3 | 2018 | 473 | 1.040 |
Why?
|
Hip Fractures | 5 | 2021 | 988 | 1.040 |
Why?
|
Governing Board | 5 | 2015 | 50 | 1.030 |
Why?
|
Internationality | 4 | 2019 | 1001 | 1.010 |
Why?
|
Hospital Information Systems | 5 | 2013 | 393 | 1.010 |
Why?
|
Safety Management | 9 | 2015 | 760 | 0.990 |
Why?
|
Hemorrhagic Fever, Ebola | 5 | 2017 | 420 | 0.990 |
Why?
|
Aged, 80 and over | 55 | 2021 | 58859 | 0.970 |
Why?
|
Disease Outbreaks | 7 | 2024 | 1762 | 0.970 |
Why?
|
Chief Executive Officers, Hospital | 2 | 2014 | 9 | 0.950 |
Why?
|
Sharks | 1 | 2024 | 21 | 0.940 |
Why?
|
Hospitals, Urban | 4 | 2016 | 500 | 0.910 |
Why?
|
Communicable Disease Control | 4 | 2018 | 848 | 0.910 |
Why?
|
Octreotide | 2 | 2024 | 153 | 0.910 |
Why?
|
Economic Competition | 2 | 2017 | 217 | 0.910 |
Why?
|
Continuity of Patient Care | 4 | 2015 | 1069 | 0.900 |
Why?
|
Costs and Cost Analysis | 8 | 2023 | 1668 | 0.900 |
Why?
|
Ambulatory Care | 8 | 2020 | 2771 | 0.900 |
Why?
|
Male | 131 | 2024 | 360035 | 0.890 |
Why?
|
Female | 130 | 2024 | 391875 | 0.860 |
Why?
|
Patient Care | 4 | 2022 | 621 | 0.850 |
Why?
|
Attitude to Computers | 4 | 2015 | 195 | 0.840 |
Why?
|
Metals, Heavy | 1 | 2024 | 147 | 0.840 |
Why?
|
Practice Management, Medical | 4 | 2013 | 191 | 0.830 |
Why?
|
Medical Errors | 5 | 2013 | 1260 | 0.830 |
Why?
|
Minority Groups | 4 | 2017 | 1201 | 0.810 |
Why?
|
Clinical Competence | 5 | 2021 | 4777 | 0.810 |
Why?
|
Terminal Care | 5 | 2021 | 1751 | 0.800 |
Why?
|
Hospitals, Pediatric | 6 | 2017 | 1859 | 0.800 |
Why?
|
State Medicine | 3 | 2019 | 214 | 0.800 |
Why?
|
Ownership | 5 | 2016 | 339 | 0.790 |
Why?
|
Patient Participation | 7 | 2018 | 1442 | 0.790 |
Why?
|
Frail Elderly | 5 | 2021 | 761 | 0.780 |
Why?
|
Salaries and Fringe Benefits | 2 | 2014 | 257 | 0.780 |
Why?
|
Pancreatitis, Chronic | 2 | 2017 | 281 | 0.770 |
Why?
|
Program Evaluation | 7 | 2018 | 2493 | 0.770 |
Why?
|
Brachial Plexus Neuritis | 1 | 2021 | 20 | 0.770 |
Why?
|
Personnel Staffing and Scheduling | 3 | 2020 | 495 | 0.760 |
Why?
|
Patient Care Management | 2 | 2014 | 302 | 0.750 |
Why?
|
Public Health Practice | 1 | 2023 | 219 | 0.740 |
Why?
|
Health Services Research | 12 | 2018 | 1811 | 0.730 |
Why?
|
Cross Infection | 5 | 2013 | 1438 | 0.730 |
Why?
|
Pandemics | 7 | 2023 | 8623 | 0.720 |
Why?
|
Emergency Service, Hospital | 6 | 2020 | 7860 | 0.720 |
Why?
|
Colonic Diseases | 2 | 2012 | 201 | 0.710 |
Why?
|
Hepatitis E virus | 1 | 2021 | 72 | 0.700 |
Why?
|
Attitude of Health Personnel | 12 | 2018 | 3880 | 0.700 |
Why?
|
Hepatitis E | 1 | 2021 | 76 | 0.690 |
Why?
|
Reimbursement Mechanisms | 5 | 2019 | 664 | 0.690 |
Why?
|
Financial Management, Hospital | 2 | 2017 | 69 | 0.690 |
Why?
|
Patient-Centered Care | 4 | 2014 | 1416 | 0.670 |
Why?
|
Health Status Disparities | 8 | 2021 | 1847 | 0.670 |
Why?
|
Health Services Administration | 1 | 2020 | 63 | 0.670 |
Why?
|
Ambulatory Care Information Systems | 2 | 2012 | 88 | 0.670 |
Why?
|
Nursing Staff | 1 | 2020 | 113 | 0.670 |
Why?
|
Catheter-Related Infections | 2 | 2013 | 273 | 0.670 |
Why?
|
Public Health | 5 | 2021 | 2665 | 0.660 |
Why?
|
Chronic Disease | 10 | 2019 | 9309 | 0.650 |
Why?
|
Data Collection | 9 | 2016 | 3321 | 0.650 |
Why?
|
Community Health Planning | 1 | 2019 | 164 | 0.640 |
Why?
|
Benchmarking | 5 | 2014 | 1045 | 0.640 |
Why?
|
Primary Health Care | 9 | 2021 | 4674 | 0.640 |
Why?
|
Ventilators, Mechanical | 2 | 2022 | 288 | 0.630 |
Why?
|
Insurance, Health | 8 | 2022 | 2491 | 0.630 |
Why?
|
United States Environmental Protection Agency | 1 | 2019 | 139 | 0.620 |
Why?
|
Social Work | 1 | 2019 | 159 | 0.600 |
Why?
|
Nuclear Medicine | 1 | 2021 | 237 | 0.600 |
Why?
|
Trichuriasis | 1 | 2017 | 24 | 0.600 |
Why?
|
Disasters | 1 | 2024 | 518 | 0.590 |
Why?
|
Ochronosis | 1 | 2017 | 7 | 0.590 |
Why?
|
Alkaptonuria | 1 | 2017 | 13 | 0.590 |
Why?
|
Nuclear Medicine Department, Hospital | 1 | 2017 | 13 | 0.580 |
Why?
|
Health Services for the Aged | 3 | 2011 | 259 | 0.580 |
Why?
|
Insurance | 1 | 2019 | 113 | 0.580 |
Why?
|
Cesium Radioisotopes | 1 | 2017 | 38 | 0.580 |
Why?
|
National Health Programs | 2 | 2018 | 440 | 0.580 |
Why?
|
Regional Health Planning | 2 | 2008 | 96 | 0.580 |
Why?
|
Gamma Cameras | 1 | 2017 | 34 | 0.580 |
Why?
|
Practice Valuation and Purchase | 1 | 2017 | 1 | 0.580 |
Why?
|
Australia | 6 | 2021 | 1245 | 0.580 |
Why?
|
Professional Practice Location | 1 | 2017 | 56 | 0.570 |
Why?
|
Sister Mary Joseph's Nodule | 1 | 2017 | 2 | 0.570 |
Why?
|
International Cooperation | 7 | 2019 | 1428 | 0.570 |
Why?
|
Neuroma, Acoustic | 1 | 2021 | 459 | 0.570 |
Why?
|
Physicians' Offices | 2 | 2014 | 60 | 0.570 |
Why?
|
Terminally Ill | 2 | 2021 | 240 | 0.570 |
Why?
|
United States Federal Trade Commission | 1 | 2017 | 10 | 0.570 |
Why?
|
Retrospective Studies | 49 | 2023 | 80430 | 0.560 |
Why?
|
Facial Dermatoses | 1 | 2017 | 86 | 0.550 |
Why?
|
Patient Discharge | 9 | 2020 | 3436 | 0.550 |
Why?
|
Public Policy | 2 | 2019 | 559 | 0.550 |
Why?
|
Public Health Administration | 1 | 2019 | 243 | 0.540 |
Why?
|
Hospital Administrators | 1 | 2016 | 57 | 0.530 |
Why?
|
Environmental Health | 1 | 2019 | 289 | 0.530 |
Why?
|
Physician Incentive Plans | 2 | 2014 | 164 | 0.530 |
Why?
|
International Agencies | 1 | 2017 | 243 | 0.530 |
Why?
|
Artificial Intelligence | 2 | 2021 | 2568 | 0.520 |
Why?
|
Hospital Records | 2 | 2013 | 93 | 0.520 |
Why?
|
Neurilemmoma | 1 | 2021 | 523 | 0.520 |
Why?
|
American Hospital Association | 5 | 2014 | 27 | 0.520 |
Why?
|
Insurance Claim Review | 7 | 2018 | 735 | 0.520 |
Why?
|
Management Information Systems | 2 | 2008 | 49 | 0.520 |
Why?
|
Marketing of Health Services | 1 | 2017 | 150 | 0.510 |
Why?
|
Disabled Persons | 4 | 2018 | 1224 | 0.510 |
Why?
|
Cross-Sectional Studies | 20 | 2021 | 26063 | 0.510 |
Why?
|
Professional Practice | 1 | 2017 | 313 | 0.500 |
Why?
|
Meningeal Neoplasms | 2 | 2024 | 1248 | 0.500 |
Why?
|
Risk Adjustment | 8 | 2017 | 599 | 0.500 |
Why?
|
Gallbladder | 1 | 2017 | 305 | 0.500 |
Why?
|
Health Facility Closure | 1 | 2015 | 25 | 0.500 |
Why?
|
Preventive Medicine | 1 | 2017 | 246 | 0.500 |
Why?
|
Medical Order Entry Systems | 4 | 2008 | 521 | 0.500 |
Why?
|
Gallbladder Neoplasms | 1 | 2017 | 190 | 0.490 |
Why?
|
Meningioma | 1 | 2024 | 1218 | 0.490 |
Why?
|
Epidemics | 2 | 2019 | 512 | 0.480 |
Why?
|
Internal Medicine | 3 | 2017 | 1051 | 0.480 |
Why?
|
Poverty Areas | 2 | 2015 | 264 | 0.470 |
Why?
|
Europe | 7 | 2021 | 3419 | 0.460 |
Why?
|
Delegation, Professional | 1 | 2013 | 2 | 0.460 |
Why?
|
Critical Care | 5 | 2015 | 2697 | 0.450 |
Why?
|
Triclosan | 2 | 2024 | 58 | 0.450 |
Why?
|
Poverty | 4 | 2020 | 2694 | 0.450 |
Why?
|
Health Facilities | 2 | 2017 | 580 | 0.450 |
Why?
|
Schools, Medical | 2 | 2018 | 878 | 0.450 |
Why?
|
Surgery Department, Hospital | 3 | 2016 | 176 | 0.440 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5296 | 0.440 |
Why?
|
Cyprinidae | 2 | 2018 | 37 | 0.440 |
Why?
|
Drug Costs | 2 | 2021 | 1179 | 0.440 |
Why?
|
Conservation of Natural Resources | 1 | 2016 | 211 | 0.440 |
Why?
|
Fish Diseases | 3 | 2017 | 37 | 0.440 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 557 | 0.440 |
Why?
|
Information Systems | 3 | 2017 | 396 | 0.430 |
Why?
|
Anti-HIV Agents | 2 | 2019 | 4518 | 0.430 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 748 | 0.430 |
Why?
|
Databases, Factual | 13 | 2020 | 7948 | 0.430 |
Why?
|
United States Department of Veterans Affairs | 6 | 2014 | 923 | 0.430 |
Why?
|
Patient Admission | 2 | 2018 | 1367 | 0.430 |
Why?
|
Hospitals, Public | 1 | 2014 | 201 | 0.430 |
Why?
|
Uncompensated Care | 1 | 2013 | 37 | 0.430 |
Why?
|
Antimalarials | 1 | 2020 | 907 | 0.430 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 1975 | 0.420 |
Why?
|
General Surgery | 2 | 2018 | 1687 | 0.420 |
Why?
|
Nursing Homes | 1 | 2020 | 1081 | 0.420 |
Why?
|
Financing, Government | 2 | 2013 | 472 | 0.410 |
Why?
|
Academic Medical Centers | 5 | 2023 | 2757 | 0.410 |
Why?
|
Health Priorities | 1 | 2015 | 374 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3080 | 0.410 |
Why?
|
Adverse Drug Reaction Reporting Systems | 3 | 2008 | 487 | 0.410 |
Why?
|
Phantoms, Imaging | 2 | 2021 | 2522 | 0.410 |
Why?
|
Rate Setting and Review | 1 | 2012 | 41 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3200 | 0.410 |
Why?
|
Social Class | 3 | 2021 | 2003 | 0.400 |
Why?
|
Health Resources | 2 | 2015 | 935 | 0.400 |
Why?
|
Length of Stay | 7 | 2019 | 6413 | 0.400 |
Why?
|
Systems Integration | 3 | 2017 | 426 | 0.400 |
Why?
|
Lutetium | 2 | 2022 | 37 | 0.400 |
Why?
|
Colonoscopy | 2 | 2017 | 1392 | 0.390 |
Why?
|
Socioeconomic Factors | 6 | 2019 | 7817 | 0.390 |
Why?
|
Splenic Rupture | 1 | 2011 | 26 | 0.390 |
Why?
|
Abdomen | 2 | 2017 | 1127 | 0.380 |
Why?
|
Mandatory Reporting | 1 | 2012 | 124 | 0.380 |
Why?
|
Gram-Negative Bacterial Infections | 4 | 2017 | 237 | 0.380 |
Why?
|
Health Services Misuse | 2 | 2013 | 244 | 0.380 |
Why?
|
Organizational Innovation | 6 | 2017 | 536 | 0.380 |
Why?
|
Neoplasms | 8 | 2021 | 22083 | 0.380 |
Why?
|
Catfishes | 2 | 2024 | 14 | 0.380 |
Why?
|
Medicare Part C | 1 | 2016 | 327 | 0.380 |
Why?
|
Uncertainty | 1 | 2016 | 753 | 0.370 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2015 | 327 | 0.370 |
Why?
|
Physician-Patient Relations | 3 | 2017 | 3246 | 0.370 |
Why?
|
Mental Disorders | 2 | 2022 | 6831 | 0.370 |
Why?
|
State Health Plans | 1 | 2013 | 219 | 0.370 |
Why?
|
Income | 6 | 2021 | 1874 | 0.370 |
Why?
|
North America | 4 | 2021 | 1275 | 0.370 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2012 | 136 | 0.370 |
Why?
|
Information Services | 2 | 2010 | 236 | 0.370 |
Why?
|
Coronary Artery Bypass | 6 | 2014 | 2188 | 0.370 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2016 | 0.360 |
Why?
|
Environmental Monitoring | 4 | 2024 | 1453 | 0.360 |
Why?
|
Multivariate Analysis | 12 | 2017 | 12054 | 0.360 |
Why?
|
Nails | 1 | 2012 | 295 | 0.360 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1654 | 0.360 |
Why?
|
Malaria | 1 | 2020 | 1225 | 0.350 |
Why?
|
Patients | 1 | 2016 | 905 | 0.350 |
Why?
|
Middle Aged | 48 | 2024 | 220382 | 0.340 |
Why?
|
Angioplasty | 1 | 2012 | 354 | 0.340 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13312 | 0.340 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2012 | 243 | 0.340 |
Why?
|
Organizational Policy | 1 | 2012 | 432 | 0.340 |
Why?
|
Physician Assistants | 1 | 2012 | 190 | 0.340 |
Why?
|
Office Visits | 2 | 2014 | 594 | 0.340 |
Why?
|
Regional Medical Programs | 1 | 2010 | 66 | 0.340 |
Why?
|
Natural Language Processing | 3 | 2023 | 1144 | 0.330 |
Why?
|
Residence Characteristics | 3 | 2021 | 2087 | 0.330 |
Why?
|
HIV Infections | 3 | 2022 | 17328 | 0.330 |
Why?
|
Fingers | 1 | 2012 | 506 | 0.330 |
Why?
|
Liver Failure, Acute | 1 | 2011 | 181 | 0.330 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 981 | 0.330 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 824 | 0.330 |
Why?
|
Nurse Practitioners | 1 | 2012 | 270 | 0.320 |
Why?
|
Linear Models | 7 | 2021 | 5865 | 0.320 |
Why?
|
Liver Failure | 1 | 2011 | 250 | 0.320 |
Why?
|
Spinal Fractures | 1 | 2015 | 705 | 0.320 |
Why?
|
Wuchereria bancrofti | 1 | 2008 | 20 | 0.320 |
Why?
|
Filariasis | 1 | 2008 | 26 | 0.310 |
Why?
|
Gross Domestic Product | 2 | 2019 | 78 | 0.310 |
Why?
|
Medical Informatics Applications | 1 | 2010 | 178 | 0.310 |
Why?
|
Confidence Intervals | 4 | 2019 | 2927 | 0.310 |
Why?
|
Policy Making | 4 | 2018 | 540 | 0.310 |
Why?
|
Access to Information | 1 | 2011 | 316 | 0.310 |
Why?
|
Efficiency | 1 | 2011 | 476 | 0.310 |
Why?
|
Point-of-Care Systems | 2 | 2017 | 1212 | 0.300 |
Why?
|
Mental Health Services | 1 | 2020 | 1730 | 0.300 |
Why?
|
India | 4 | 2019 | 2341 | 0.300 |
Why?
|
Inpatients | 2 | 2017 | 2545 | 0.300 |
Why?
|
Postoperative Complications | 8 | 2018 | 15627 | 0.300 |
Why?
|
Intestinal Obstruction | 1 | 2012 | 432 | 0.300 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 8967 | 0.300 |
Why?
|
Nepal | 3 | 2019 | 304 | 0.300 |
Why?
|
Organizational Culture | 1 | 2011 | 508 | 0.300 |
Why?
|
Breast Neoplasms, Male | 1 | 2010 | 219 | 0.300 |
Why?
|
Logistic Models | 11 | 2020 | 13240 | 0.300 |
Why?
|
Surface-Active Agents | 1 | 2008 | 149 | 0.290 |
Why?
|
Health Records, Personal | 1 | 2009 | 127 | 0.290 |
Why?
|
Respiratory Burst | 2 | 2007 | 110 | 0.290 |
Why?
|
Canada | 3 | 2019 | 2119 | 0.290 |
Why?
|
Medication Systems, Hospital | 1 | 2008 | 154 | 0.290 |
Why?
|
Accidental Falls | 1 | 2015 | 1066 | 0.290 |
Why?
|
Risk Assessment | 12 | 2024 | 23953 | 0.290 |
Why?
|
Esophagectomy | 1 | 2011 | 465 | 0.280 |
Why?
|
Massachusetts | 8 | 2019 | 8826 | 0.280 |
Why?
|
Geologic Sediments | 2 | 2024 | 80 | 0.280 |
Why?
|
Chickenpox | 1 | 2007 | 96 | 0.280 |
Why?
|
Rare Diseases | 1 | 2012 | 621 | 0.280 |
Why?
|
Pancytopenia | 1 | 2008 | 102 | 0.280 |
Why?
|
Cesarean Section | 1 | 2015 | 1393 | 0.280 |
Why?
|
Diagnosis-Related Groups | 5 | 2014 | 449 | 0.280 |
Why?
|
Adult | 37 | 2024 | 220781 | 0.270 |
Why?
|
Sex Factors | 6 | 2021 | 10538 | 0.270 |
Why?
|
Odds Ratio | 8 | 2018 | 9639 | 0.270 |
Why?
|
Adenocarcinoma | 4 | 2017 | 6330 | 0.270 |
Why?
|
Peripheral Vascular Diseases | 1 | 2009 | 488 | 0.270 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2014 | 936 | 0.270 |
Why?
|
State Government | 3 | 2019 | 384 | 0.270 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2007 | 131 | 0.270 |
Why?
|
Esophageal and Gastric Varices | 2 | 2018 | 208 | 0.270 |
Why?
|
Influenza, Human | 3 | 2018 | 1517 | 0.270 |
Why?
|
Africa | 3 | 2019 | 709 | 0.270 |
Why?
|
Cross-Cultural Comparison | 2 | 2021 | 636 | 0.260 |
Why?
|
Disclosure | 2 | 2016 | 748 | 0.260 |
Why?
|
Information Storage and Retrieval | 1 | 2011 | 819 | 0.260 |
Why?
|
Industry | 1 | 2008 | 364 | 0.260 |
Why?
|
Rehabilitation Centers | 2 | 2021 | 248 | 0.260 |
Why?
|
Activities of Daily Living | 1 | 2015 | 2420 | 0.250 |
Why?
|
Appointments and Schedules | 1 | 2009 | 443 | 0.250 |
Why?
|
Minerals | 2 | 2024 | 284 | 0.250 |
Why?
|
Receptors, Peptide | 2 | 2024 | 279 | 0.250 |
Why?
|
Cohort Studies | 13 | 2023 | 41366 | 0.250 |
Why?
|
Arterial Occlusive Diseases | 1 | 2009 | 748 | 0.250 |
Why?
|
Critical Illness | 1 | 2018 | 2722 | 0.250 |
Why?
|
Population Surveillance | 2 | 2013 | 2603 | 0.250 |
Why?
|
Health Benefit Plans, Employee | 1 | 2008 | 333 | 0.250 |
Why?
|
Diagnostic Tests, Routine | 2 | 2009 | 786 | 0.250 |
Why?
|
Herpes Zoster | 1 | 2007 | 253 | 0.250 |
Why?
|
Workload | 1 | 2011 | 844 | 0.250 |
Why?
|
Episode of Care | 2 | 2016 | 127 | 0.240 |
Why?
|
Diabetes Mellitus | 4 | 2021 | 5835 | 0.240 |
Why?
|
Medicine | 1 | 2013 | 941 | 0.240 |
Why?
|
Immunization Programs | 1 | 2007 | 268 | 0.240 |
Why?
|
Evidence-Based Medicine | 3 | 2017 | 3685 | 0.240 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2241 | 0.240 |
Why?
|
Infection Control | 1 | 2012 | 985 | 0.240 |
Why?
|
Tuberculosis, Miliary | 1 | 2004 | 13 | 0.240 |
Why?
|
Adjuvants, Immunologic | 2 | 2007 | 1035 | 0.230 |
Why?
|
Leg | 1 | 2009 | 1089 | 0.230 |
Why?
|
Colon | 1 | 2012 | 1791 | 0.230 |
Why?
|
Yttrium | 1 | 2024 | 33 | 0.230 |
Why?
|
Rivers | 1 | 2024 | 64 | 0.230 |
Why?
|
Dietary Supplements | 3 | 2018 | 3405 | 0.230 |
Why?
|
Federal Government | 2 | 2017 | 267 | 0.230 |
Why?
|
Medically Uninsured | 3 | 2015 | 834 | 0.230 |
Why?
|
Developing Countries | 4 | 2020 | 2882 | 0.230 |
Why?
|
Hospice Care | 2 | 2022 | 677 | 0.220 |
Why?
|
Health Services | 2 | 2020 | 752 | 0.220 |
Why?
|
Emergency Medical Services | 1 | 2015 | 1918 | 0.220 |
Why?
|
Health Personnel | 4 | 2020 | 3331 | 0.220 |
Why?
|
Age Factors | 6 | 2018 | 18379 | 0.220 |
Why?
|
Total Quality Management | 1 | 2004 | 264 | 0.210 |
Why?
|
Treatment Outcome | 19 | 2024 | 64591 | 0.210 |
Why?
|
Risk | 4 | 2020 | 9605 | 0.210 |
Why?
|
Immunity, Innate | 3 | 2018 | 3059 | 0.210 |
Why?
|
Attitude to Health | 3 | 2008 | 2025 | 0.210 |
Why?
|
Trace Elements | 1 | 2024 | 195 | 0.210 |
Why?
|
Confidentiality | 3 | 2019 | 609 | 0.210 |
Why?
|
Colonic Neoplasms | 2 | 2012 | 2529 | 0.210 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2002 | 23 | 0.200 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 1085 | 0.200 |
Why?
|
Intensive Care Units | 4 | 2021 | 3742 | 0.200 |
Why?
|
Lypressin | 2 | 2018 | 26 | 0.200 |
Why?
|
Medication Errors | 1 | 2008 | 783 | 0.200 |
Why?
|
Glutathione Transferase | 1 | 2024 | 565 | 0.200 |
Why?
|
Fever of Unknown Origin | 1 | 2002 | 94 | 0.200 |
Why?
|
Time Factors | 14 | 2020 | 39947 | 0.200 |
Why?
|
Rectal Neoplasms | 3 | 2017 | 1157 | 0.200 |
Why?
|
Radioimmunotherapy | 1 | 2021 | 91 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20551 | 0.190 |
Why?
|
Rectal Fistula | 1 | 2021 | 75 | 0.190 |
Why?
|
Carcinoma | 2 | 2023 | 2328 | 0.190 |
Why?
|
Insurance Carriers | 2 | 2022 | 155 | 0.190 |
Why?
|
Health Services Needs and Demand | 2 | 2021 | 1403 | 0.180 |
Why?
|
Cranial Nerves | 1 | 2021 | 98 | 0.180 |
Why?
|
Physicians, Women | 2 | 2017 | 507 | 0.180 |
Why?
|
Fluorescein | 1 | 2021 | 174 | 0.180 |
Why?
|
Hot Temperature | 2 | 2018 | 1440 | 0.180 |
Why?
|
Acute Disease | 5 | 2018 | 7230 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1646 | 0.180 |
Why?
|
Politics | 2 | 2018 | 814 | 0.180 |
Why?
|
Models, Organizational | 3 | 2018 | 546 | 0.180 |
Why?
|
Cost of Illness | 4 | 2020 | 1931 | 0.180 |
Why?
|
Vascular Surgical Procedures | 1 | 2009 | 1490 | 0.180 |
Why?
|
Medication Adherence | 1 | 2012 | 2166 | 0.180 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2007 | 1351 | 0.180 |
Why?
|
Models, Economic | 3 | 2016 | 716 | 0.180 |
Why?
|
Clinical Laboratory Information Systems | 3 | 2008 | 109 | 0.180 |
Why?
|
Cystatin C | 1 | 2022 | 270 | 0.180 |
Why?
|
Organometallic Compounds | 1 | 2024 | 649 | 0.180 |
Why?
|
Nursing Staff, Hospital | 2 | 2017 | 348 | 0.180 |
Why?
|
Prostate-Specific Antigen | 2 | 2022 | 2464 | 0.180 |
Why?
|
Sepsis | 2 | 2011 | 2583 | 0.170 |
Why?
|
Dipeptides | 1 | 2022 | 391 | 0.170 |
Why?
|
Ecosystem | 1 | 2024 | 489 | 0.170 |
Why?
|
Managed Care Programs | 2 | 2017 | 940 | 0.170 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12969 | 0.170 |
Why?
|
Radiometry | 2 | 2022 | 813 | 0.170 |
Why?
|
Thoracic Surgery | 1 | 2006 | 722 | 0.170 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2019 | 43 | 0.170 |
Why?
|
Internet | 1 | 2012 | 3092 | 0.170 |
Why?
|
Dust | 1 | 2022 | 487 | 0.170 |
Why?
|
Medical Oncology | 2 | 2022 | 2318 | 0.170 |
Why?
|
Liver Abscess, Amebic | 1 | 2019 | 20 | 0.170 |
Why?
|
Forecasting | 4 | 2013 | 2925 | 0.160 |
Why?
|
Chi-Square Distribution | 4 | 2009 | 3418 | 0.160 |
Why?
|
Survival Analysis | 6 | 2017 | 10075 | 0.160 |
Why?
|
Geriatric Assessment | 2 | 2018 | 1409 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2022 | 1925 | 0.160 |
Why?
|
Ancillary Services, Hospital | 1 | 1998 | 23 | 0.160 |
Why?
|
Prospective Payment System | 2 | 2017 | 136 | 0.160 |
Why?
|
Locomotion | 1 | 2021 | 388 | 0.160 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2018 | 92 | 0.160 |
Why?
|
Government Programs | 1 | 2020 | 279 | 0.160 |
Why?
|
Chordoma | 1 | 2021 | 346 | 0.150 |
Why?
|
Risk Factors | 13 | 2018 | 74055 | 0.150 |
Why?
|
Phenylketonurias | 1 | 2019 | 126 | 0.150 |
Why?
|
Government Regulation | 2 | 2020 | 524 | 0.150 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 270 | 0.150 |
Why?
|
Colon, Ascending | 1 | 2017 | 14 | 0.150 |
Why?
|
World Health Organization | 3 | 2024 | 1315 | 0.150 |
Why?
|
Accidents, Occupational | 1 | 2019 | 249 | 0.150 |
Why?
|
Security Measures | 1 | 2018 | 82 | 0.150 |
Why?
|
Trichuris | 1 | 2017 | 32 | 0.150 |
Why?
|
Antigens, Surface | 1 | 2022 | 1608 | 0.150 |
Why?
|
Social Conditions | 1 | 2018 | 119 | 0.150 |
Why?
|
Public Sector | 1 | 2019 | 267 | 0.150 |
Why?
|
Video-Assisted Surgery | 1 | 2017 | 51 | 0.150 |
Why?
|
Steatorrhea | 1 | 2017 | 4 | 0.150 |
Why?
|
Bone Marrow | 1 | 2008 | 2907 | 0.140 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2019 | 122 | 0.140 |
Why?
|
Proctoscopy | 1 | 2017 | 40 | 0.140 |
Why?
|
End Stage Liver Disease | 1 | 2022 | 352 | 0.140 |
Why?
|
Financing, Personal | 1 | 2020 | 309 | 0.140 |
Why?
|
Computer Systems | 2 | 1998 | 471 | 0.140 |
Why?
|
Mass Screening | 2 | 2017 | 5424 | 0.140 |
Why?
|
Young Adult | 11 | 2020 | 59068 | 0.140 |
Why?
|
Radiopharmaceuticals | 2 | 2024 | 2646 | 0.140 |
Why?
|
Spinal Cord Neoplasms | 1 | 2019 | 263 | 0.140 |
Why?
|
Anus Neoplasms | 1 | 2021 | 329 | 0.140 |
Why?
|
California | 2 | 2019 | 1426 | 0.140 |
Why?
|
Guideline Adherence | 3 | 2017 | 2215 | 0.140 |
Why?
|
Drug Monitoring | 2 | 2001 | 961 | 0.140 |
Why?
|
Dermoscopy | 1 | 2017 | 66 | 0.140 |
Why?
|
Breast Neoplasms | 6 | 2022 | 20985 | 0.140 |
Why?
|
Cecum | 1 | 2017 | 233 | 0.140 |
Why?
|
Organizational Affiliation | 1 | 2016 | 34 | 0.140 |
Why?
|
Pancreatic Pseudocyst | 1 | 2017 | 110 | 0.140 |
Why?
|
Veterans | 2 | 2007 | 2642 | 0.140 |
Why?
|
Organizational Case Studies | 1 | 2017 | 301 | 0.140 |
Why?
|
Radioisotopes | 3 | 2023 | 497 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2023 | 642 | 0.140 |
Why?
|
Emigration and Immigration | 1 | 2019 | 396 | 0.140 |
Why?
|
Hospital Charges | 2 | 2014 | 351 | 0.140 |
Why?
|
Disease Management | 2 | 2019 | 2501 | 0.130 |
Why?
|
Health Surveys | 3 | 2020 | 4056 | 0.130 |
Why?
|
Melanosis | 1 | 2017 | 93 | 0.130 |
Why?
|
Hypertension, Portal | 1 | 2018 | 226 | 0.130 |
Why?
|
Adolescent | 15 | 2020 | 88196 | 0.130 |
Why?
|
Penile Neoplasms | 1 | 2017 | 161 | 0.130 |
Why?
|
Cause of Death | 2 | 2018 | 3686 | 0.130 |
Why?
|
Tryptophan | 1 | 2018 | 482 | 0.130 |
Why?
|
Motivation | 3 | 2013 | 2006 | 0.130 |
Why?
|
Models, Statistical | 2 | 2008 | 5078 | 0.130 |
Why?
|
Telemedicine | 1 | 2013 | 3027 | 0.130 |
Why?
|
Child | 10 | 2020 | 80086 | 0.130 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2018 | 1116 | 0.130 |
Why?
|
Survival Rate | 3 | 2021 | 12698 | 0.130 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2007 | 2151 | 0.130 |
Why?
|
Societies, Hospital | 1 | 2015 | 6 | 0.130 |
Why?
|
Laparoscopy | 2 | 2017 | 2035 | 0.130 |
Why?
|
Iatrogenic Disease | 1 | 2019 | 538 | 0.130 |
Why?
|
Poisson Distribution | 1 | 2017 | 504 | 0.130 |
Why?
|
Outpatients | 1 | 2023 | 1596 | 0.130 |
Why?
|
Algorithms | 6 | 2022 | 14002 | 0.130 |
Why?
|
Prospective Studies | 10 | 2023 | 54339 | 0.130 |
Why?
|
Investments | 2 | 2015 | 147 | 0.120 |
Why?
|
Transportation | 1 | 2017 | 216 | 0.120 |
Why?
|
Pregnancy, High-Risk | 1 | 2015 | 122 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 952 | 0.120 |
Why?
|
Quality of Life | 4 | 2023 | 13338 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2015 | 70 | 0.120 |
Why?
|
Utilization Review | 2 | 2013 | 382 | 0.120 |
Why?
|
Administrative Personnel | 1 | 2016 | 184 | 0.120 |
Why?
|
Health Care Sector | 1 | 2017 | 194 | 0.120 |
Why?
|
E-Selectin | 1 | 2017 | 576 | 0.120 |
Why?
|
Animal Feed | 3 | 2017 | 113 | 0.120 |
Why?
|
Vasoconstrictor Agents | 1 | 2018 | 653 | 0.120 |
Why?
|
International Classification of Diseases | 2 | 2018 | 892 | 0.120 |
Why?
|
Growth Charts | 1 | 2015 | 60 | 0.120 |
Why?
|
Equipment Failure Analysis | 1 | 2017 | 847 | 0.120 |
Why?
|
Demography | 1 | 2019 | 1648 | 0.120 |
Why?
|
Child, Preschool | 7 | 2020 | 42209 | 0.120 |
Why?
|
Research | 3 | 2019 | 1977 | 0.120 |
Why?
|
Prevalence | 3 | 2019 | 15698 | 0.120 |
Why?
|
Achievement | 1 | 2016 | 289 | 0.120 |
Why?
|
Geography | 1 | 2016 | 658 | 0.120 |
Why?
|
Science | 1 | 2017 | 239 | 0.120 |
Why?
|
Long-Term Care | 1 | 2018 | 633 | 0.120 |
Why?
|
Liver Cirrhosis | 2 | 2020 | 1934 | 0.110 |
Why?
|
Clinical Coding | 1 | 2015 | 180 | 0.110 |
Why?
|
Health Maintenance Organizations | 1 | 2017 | 660 | 0.110 |
Why?
|
Mediastinitis | 1 | 2013 | 49 | 0.110 |
Why?
|
Embolization, Therapeutic | 1 | 2024 | 1418 | 0.110 |
Why?
|
Curcumin | 1 | 2015 | 98 | 0.110 |
Why?
|
Central Nervous System | 1 | 2021 | 1337 | 0.110 |
Why?
|
Infant | 7 | 2020 | 36183 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4020 | 0.110 |
Why?
|
Communication Barriers | 1 | 2017 | 413 | 0.110 |
Why?
|
Drug Combinations | 1 | 2019 | 2043 | 0.110 |
Why?
|
Hospices | 1 | 2016 | 245 | 0.110 |
Why?
|
Fatal Outcome | 2 | 2011 | 1832 | 0.110 |
Why?
|
Registries | 3 | 2021 | 8216 | 0.110 |
Why?
|
Stroke | 2 | 2015 | 9745 | 0.110 |
Why?
|
Community-Acquired Infections | 1 | 2017 | 468 | 0.110 |
Why?
|
Interinstitutional Relations | 1 | 2014 | 236 | 0.110 |
Why?
|
Drainage | 1 | 2019 | 1155 | 0.110 |
Why?
|
Radiation Dosage | 1 | 2021 | 1958 | 0.110 |
Why?
|
Radiotherapy | 1 | 2019 | 1498 | 0.100 |
Why?
|
Group Practice | 2 | 2011 | 151 | 0.100 |
Why?
|
Social Security | 1 | 2013 | 101 | 0.100 |
Why?
|
Necrosis | 1 | 2017 | 1604 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15820 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2018 | 700 | 0.100 |
Why?
|
Zinc | 1 | 2017 | 689 | 0.100 |
Why?
|
Legislation, Hospital | 1 | 2012 | 11 | 0.100 |
Why?
|
Parity | 1 | 2015 | 927 | 0.100 |
Why?
|
Economics | 1 | 2013 | 141 | 0.100 |
Why?
|
Organizational Objectives | 1 | 2014 | 426 | 0.100 |
Why?
|
Prognosis | 6 | 2023 | 29551 | 0.100 |
Why?
|
Organizations | 1 | 2013 | 171 | 0.100 |
Why?
|
Health Status | 3 | 2018 | 4071 | 0.100 |
Why?
|
Fever | 1 | 2020 | 1618 | 0.100 |
Why?
|
Antiprotozoal Agents | 1 | 2012 | 94 | 0.100 |
Why?
|
Phosphorylcholine | 1 | 2012 | 153 | 0.100 |
Why?
|
Advance Care Planning | 1 | 2019 | 694 | 0.100 |
Why?
|
Denmark | 1 | 2014 | 766 | 0.100 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39078 | 0.100 |
Why?
|
Republic of Korea | 1 | 2014 | 571 | 0.100 |
Why?
|
Injury Severity Score | 1 | 2015 | 1045 | 0.100 |
Why?
|
Leishmaniasis, Visceral | 1 | 2012 | 99 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 1 | 2017 | 1118 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20078 | 0.100 |
Why?
|
Age Distribution | 2 | 2007 | 2878 | 0.100 |
Why?
|
Viral Vaccines | 1 | 2017 | 596 | 0.090 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1273 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2007 | 1240 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2019 | 1185 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2297 | 0.090 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2015 | 651 | 0.090 |
Why?
|
Program Development | 2 | 2018 | 1297 | 0.090 |
Why?
|
Japan | 1 | 2015 | 1366 | 0.090 |
Why?
|
Communicable Diseases | 1 | 2019 | 879 | 0.090 |
Why?
|
Life Expectancy | 1 | 2018 | 1240 | 0.090 |
Why?
|
Bronchiolitis | 1 | 2017 | 485 | 0.090 |
Why?
|
Lead | 1 | 2017 | 879 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 556 | 0.090 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2015 | 621 | 0.090 |
Why?
|
Duodenal Neoplasms | 1 | 2011 | 115 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2021 | 1410 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1494 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1383 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 362 | 0.090 |
Why?
|
Aeromonas hydrophila | 2 | 2007 | 10 | 0.090 |
Why?
|
Genomic Instability | 1 | 2015 | 709 | 0.090 |
Why?
|
Goals | 1 | 2016 | 711 | 0.090 |
Why?
|
Random Allocation | 3 | 2017 | 2388 | 0.090 |
Why?
|
Private Practice | 1 | 2011 | 152 | 0.090 |
Why?
|
Cost-Benefit Analysis | 5 | 2024 | 5491 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2017 | 1317 | 0.090 |
Why?
|
Bacteremia | 2 | 2012 | 979 | 0.090 |
Why?
|
Employment | 1 | 2016 | 1114 | 0.090 |
Why?
|
Software | 2 | 2023 | 4426 | 0.090 |
Why?
|
Biopsy | 2 | 2012 | 6765 | 0.090 |
Why?
|
Trauma Centers | 1 | 2015 | 937 | 0.090 |
Why?
|
Muramidase | 2 | 2007 | 169 | 0.090 |
Why?
|
Viral Load | 1 | 2019 | 3329 | 0.080 |
Why?
|
Splenectomy | 1 | 2011 | 391 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2017 | 3596 | 0.080 |
Why?
|
Electronic Prescribing | 1 | 2010 | 114 | 0.080 |
Why?
|
Animals | 12 | 2024 | 168253 | 0.080 |
Why?
|
Hospitals, General | 2 | 2011 | 798 | 0.080 |
Why?
|
Medically Underserved Area | 1 | 2011 | 256 | 0.080 |
Why?
|
Disease Progression | 2 | 2024 | 13484 | 0.080 |
Why?
|
Interdisciplinary Communication | 2 | 2016 | 931 | 0.080 |
Why?
|
Therapeutic Human Experimentation | 1 | 2009 | 43 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2112 | 0.080 |
Why?
|
Health Plan Implementation | 1 | 2012 | 337 | 0.080 |
Why?
|
Equipment Design | 1 | 2017 | 3510 | 0.080 |
Why?
|
Australasia | 1 | 2008 | 21 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2021 | 11096 | 0.080 |
Why?
|
Coronary Disease | 1 | 2003 | 5919 | 0.080 |
Why?
|
Cetrimonium Compounds | 1 | 2008 | 4 | 0.080 |
Why?
|
Travel | 1 | 2015 | 795 | 0.080 |
Why?
|
Needs Assessment | 1 | 2015 | 1139 | 0.080 |
Why?
|
Standard of Care | 1 | 2012 | 550 | 0.080 |
Why?
|
Lung | 2 | 2023 | 9973 | 0.080 |
Why?
|
Air Pollutants | 1 | 2022 | 2870 | 0.080 |
Why?
|
Statistics as Topic | 2 | 2011 | 2357 | 0.080 |
Why?
|
Calcinosis | 1 | 2017 | 1469 | 0.080 |
Why?
|
Financial Management | 1 | 2010 | 160 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12127 | 0.080 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2008 | 102 | 0.080 |
Why?
|
Anemia, Megaloblastic | 1 | 2008 | 24 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2015 | 1264 | 0.080 |
Why?
|
Neutrons | 1 | 2008 | 77 | 0.080 |
Why?
|
Polystyrenes | 1 | 2008 | 104 | 0.080 |
Why?
|
Adsorption | 1 | 2008 | 197 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4319 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3541 | 0.070 |
Why?
|
Spinal Cord Injuries | 1 | 2015 | 924 | 0.070 |
Why?
|
Pneumonia, Bacterial | 1 | 2010 | 316 | 0.070 |
Why?
|
Bone Marrow Examination | 1 | 2008 | 154 | 0.070 |
Why?
|
Cations | 1 | 2008 | 238 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2019 | 2070 | 0.070 |
Why?
|
Health Care Coalitions | 1 | 2007 | 36 | 0.070 |
Why?
|
Entropy | 1 | 2008 | 210 | 0.070 |
Why?
|
Physicians, Family | 1 | 2009 | 349 | 0.070 |
Why?
|
Immunocompetence | 1 | 2007 | 138 | 0.070 |
Why?
|
Benzenesulfonates | 1 | 2008 | 166 | 0.070 |
Why?
|
Micelles | 1 | 2008 | 192 | 0.070 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2015 | 989 | 0.070 |
Why?
|
Language | 1 | 2017 | 1537 | 0.070 |
Why?
|
Anemia | 1 | 2017 | 1508 | 0.070 |
Why?
|
Computer Simulation | 1 | 2021 | 6230 | 0.070 |
Why?
|
Prostatic Neoplasms | 2 | 2022 | 11095 | 0.070 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1475 | 0.070 |
Why?
|
Death | 2 | 2022 | 676 | 0.070 |
Why?
|
Pressure Ulcer | 1 | 2008 | 156 | 0.070 |
Why?
|
Fructans | 1 | 2006 | 4 | 0.070 |
Why?
|
Carps | 1 | 2006 | 51 | 0.070 |
Why?
|
Erythrocyte Count | 1 | 2007 | 157 | 0.070 |
Why?
|
Leadership | 1 | 2016 | 1379 | 0.070 |
Why?
|
Thermodynamics | 1 | 2008 | 595 | 0.070 |
Why?
|
Scattering, Radiation | 1 | 2008 | 490 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1726 | 0.070 |
Why?
|
RNA, Fungal | 1 | 2007 | 161 | 0.070 |
Why?
|
Pain | 2 | 2017 | 5075 | 0.070 |
Why?
|
Urinary Tract Infections | 1 | 2012 | 806 | 0.070 |
Why?
|
Alcoholism | 1 | 2017 | 1972 | 0.070 |
Why?
|
Resuscitation Orders | 1 | 2008 | 270 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4903 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4240 | 0.070 |
Why?
|
Myocardial Reperfusion | 1 | 2007 | 338 | 0.060 |
Why?
|
Michigan | 1 | 2006 | 339 | 0.060 |
Why?
|
Anemia, Aplastic | 1 | 2008 | 228 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14661 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6168 | 0.060 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 1549 | 0.060 |
Why?
|
Creatinine | 2 | 2022 | 1898 | 0.060 |
Why?
|
Aspirin | 2 | 2007 | 3134 | 0.060 |
Why?
|
beta Carotene | 1 | 2007 | 523 | 0.060 |
Why?
|
Public Health Informatics | 1 | 2006 | 109 | 0.060 |
Why?
|
Physician's Role | 1 | 2012 | 916 | 0.060 |
Why?
|
Surface Properties | 1 | 2008 | 1160 | 0.060 |
Why?
|
Information Management | 1 | 2005 | 100 | 0.060 |
Why?
|
Ecotoxicology | 1 | 2024 | 6 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2011 | 871 | 0.060 |
Why?
|
Incidence | 2 | 2015 | 21322 | 0.060 |
Why?
|
Democratic Republic of the Congo | 1 | 2024 | 86 | 0.060 |
Why?
|
Gills | 1 | 2024 | 21 | 0.060 |
Why?
|
Monkeypox virus | 1 | 2024 | 42 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2020 | 26280 | 0.060 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2004 | 86 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 1525 | 0.060 |
Why?
|
Philosophy, Medical | 1 | 2004 | 79 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15257 | 0.060 |
Why?
|
Cytodiagnosis | 1 | 2008 | 447 | 0.060 |
Why?
|
Fresh Water | 1 | 2024 | 82 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2476 | 0.060 |
Why?
|
Pancreatitis | 1 | 2011 | 1096 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3868 | 0.060 |
Why?
|
Hemoglobins | 2 | 2007 | 1524 | 0.060 |
Why?
|
Jaundice | 1 | 2004 | 96 | 0.060 |
Why?
|
Catalase | 1 | 2024 | 217 | 0.060 |
Why?
|
Career Mobility | 1 | 2006 | 258 | 0.060 |
Why?
|
New York | 1 | 2006 | 872 | 0.060 |
Why?
|
Physical Examination | 1 | 2009 | 1254 | 0.050 |
Why?
|
Pneumococcal Vaccines | 1 | 2007 | 397 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5778 | 0.050 |
Why?
|
Databases as Topic | 1 | 2005 | 473 | 0.050 |
Why?
|
Models, Theoretical | 2 | 2013 | 3576 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 2 | 1999 | 747 | 0.050 |
Why?
|
Incidental Findings | 1 | 2008 | 697 | 0.050 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12429 | 0.050 |
Why?
|
Yttrium Radioisotopes | 1 | 2024 | 107 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2011 | 6230 | 0.050 |
Why?
|
England | 2 | 2015 | 527 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2007 | 1596 | 0.050 |
Why?
|
Ligands | 2 | 2022 | 3270 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3610 | 0.050 |
Why?
|
Commerce | 1 | 2008 | 604 | 0.050 |
Why?
|
Mental Health | 1 | 2017 | 3241 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13616 | 0.050 |
Why?
|
Liver | 3 | 2024 | 7531 | 0.050 |
Why?
|
Confusion | 1 | 2004 | 278 | 0.050 |
Why?
|
Glioma | 1 | 2017 | 3434 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5292 | 0.050 |
Why?
|
Sex Distribution | 1 | 2007 | 2281 | 0.050 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2022 | 68 | 0.050 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2022 | 81 | 0.050 |
Why?
|
Alkenes | 1 | 2001 | 54 | 0.050 |
Why?
|
ROC Curve | 2 | 2022 | 3571 | 0.050 |
Why?
|
Pilot Projects | 2 | 2021 | 8611 | 0.050 |
Why?
|
Palliative Care | 1 | 2017 | 3585 | 0.050 |
Why?
|
Blood Proteins | 1 | 2007 | 1174 | 0.050 |
Why?
|
Superoxide Dismutase | 1 | 2024 | 592 | 0.050 |
Why?
|
Government | 1 | 2022 | 161 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2008 | 0.050 |
Why?
|
Temperature | 1 | 2008 | 2228 | 0.050 |
Why?
|
Vaccination | 2 | 2018 | 3375 | 0.050 |
Why?
|
Agriculture | 1 | 2002 | 190 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6894 | 0.050 |
Why?
|
Microspheres | 1 | 2024 | 787 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7380 | 0.040 |
Why?
|
Knee | 1 | 2002 | 279 | 0.040 |
Why?
|
DNA Methylation | 1 | 2015 | 4383 | 0.040 |
Why?
|
Autopsy | 1 | 2004 | 1005 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1517 | 0.040 |
Why?
|
Boston | 3 | 2008 | 9326 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2002 | 437 | 0.040 |
Why?
|
Pregnancy | 2 | 2015 | 29831 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 4416 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2007 | 1731 | 0.040 |
Why?
|
Eating | 1 | 2007 | 1535 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2024 | 1844 | 0.040 |
Why?
|
Decision Support Systems, Clinical | 2 | 2007 | 1172 | 0.040 |
Why?
|
Blood | 1 | 2002 | 584 | 0.040 |
Why?
|
Aerosols | 1 | 2022 | 631 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2024 | 2265 | 0.040 |
Why?
|
Urban Population | 1 | 2007 | 2032 | 0.040 |
Why?
|
Leukemia | 1 | 2008 | 1522 | 0.040 |
Why?
|
Hospital Communication Systems | 1 | 1999 | 48 | 0.040 |
Why?
|
Pseudohypoparathyroidism | 1 | 2000 | 87 | 0.040 |
Why?
|
Trees | 1 | 1999 | 54 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2017 | 5143 | 0.040 |
Why?
|
Quarantine | 1 | 2021 | 181 | 0.040 |
Why?
|
Anal Canal | 1 | 2021 | 373 | 0.040 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 1999 | 100 | 0.040 |
Why?
|
Asthma | 1 | 2018 | 6195 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22097 | 0.040 |
Why?
|
Bilirubin | 1 | 2020 | 437 | 0.040 |
Why?
|
Skull Base | 1 | 2021 | 292 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9468 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9267 | 0.040 |
Why?
|
Portal Pressure | 1 | 2018 | 60 | 0.040 |
Why?
|
Computers | 1 | 2001 | 596 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5359 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2022 | 1146 | 0.040 |
Why?
|
Contrast Media | 1 | 2011 | 5310 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3587 | 0.040 |
Why?
|
Emergencies | 1 | 2024 | 1217 | 0.040 |
Why?
|
Inguinal Canal | 1 | 2017 | 71 | 0.040 |
Why?
|
Fungemia | 1 | 1997 | 57 | 0.040 |
Why?
|
Therapy, Computer-Assisted | 1 | 1999 | 266 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 554 | 0.040 |
Why?
|
Exanthema | 1 | 2002 | 504 | 0.040 |
Why?
|
Pharmacoepidemiology | 1 | 2001 | 350 | 0.040 |
Why?
|
Aeromonas | 1 | 2017 | 16 | 0.040 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2007 | 1389 | 0.040 |
Why?
|
Data Display | 1 | 1997 | 175 | 0.040 |
Why?
|
Rural Population | 1 | 2007 | 2279 | 0.040 |
Why?
|
Germany | 1 | 2019 | 873 | 0.040 |
Why?
|
Varicose Veins | 1 | 2018 | 155 | 0.040 |
Why?
|
Heat-Shock Response | 1 | 2018 | 179 | 0.030 |
Why?
|
Fatigue | 1 | 2004 | 1550 | 0.030 |
Why?
|
Medical Audit | 1 | 1998 | 453 | 0.030 |
Why?
|
Perineum | 1 | 2017 | 208 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2007 | 2117 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2018 | 1379 | 0.030 |
Why?
|
Water | 1 | 2022 | 1409 | 0.030 |
Why?
|
Consensus | 1 | 2006 | 3115 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 495 | 0.030 |
Why?
|
Medicare Part B | 1 | 2017 | 117 | 0.030 |
Why?
|
Kidney | 2 | 2024 | 7046 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36362 | 0.030 |
Why?
|
Catheters | 1 | 2019 | 426 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1807 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9003 | 0.030 |
Why?
|
Oxygen | 1 | 2007 | 4222 | 0.030 |
Why?
|
Laparotomy | 1 | 2017 | 457 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2007 | 2750 | 0.030 |
Why?
|
Africa South of the Sahara | 1 | 2018 | 743 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 911 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2852 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1887 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2898 | 0.030 |
Why?
|
Risk Management | 1 | 1998 | 557 | 0.030 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2021 | 801 | 0.030 |
Why?
|
Chromosome Breakage | 1 | 2015 | 159 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2015 | 451 | 0.030 |
Why?
|
Dyspnea | 1 | 2002 | 1344 | 0.030 |
Why?
|
Diet | 2 | 2017 | 8058 | 0.030 |
Why?
|
Hospitals, University | 1 | 1995 | 564 | 0.030 |
Why?
|
Erectile Dysfunction | 1 | 2017 | 444 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2217 | 0.030 |
Why?
|
Biomedical Research | 1 | 2009 | 3421 | 0.030 |
Why?
|
Clinical Governance | 1 | 2013 | 7 | 0.030 |
Why?
|
Radiography | 1 | 2004 | 6963 | 0.030 |
Why?
|
Culture | 1 | 2017 | 623 | 0.030 |
Why?
|
Scotland | 1 | 2013 | 143 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2003 | 6813 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2024 | 3108 | 0.030 |
Why?
|
Comorbidity | 1 | 2007 | 10494 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 1997 | 621 | 0.030 |
Why?
|
Rectum | 1 | 2017 | 892 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 716 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2017 | 6128 | 0.020 |
Why?
|
Nerve Block | 1 | 2019 | 704 | 0.020 |
Why?
|
Infant, Premature, Diseases | 1 | 2017 | 710 | 0.020 |
Why?
|
Flavonoids | 1 | 1994 | 444 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2022 | 2805 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3088 | 0.020 |
Why?
|
Influenza Vaccines | 1 | 2018 | 763 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4849 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6471 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1400 | 0.020 |
Why?
|
Tuberculosis | 1 | 2002 | 2012 | 0.020 |
Why?
|
Health Behavior | 1 | 2020 | 2637 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3590 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2007 | 7424 | 0.020 |
Why?
|
Learning | 1 | 2018 | 1740 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2015 | 1142 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14565 | 0.020 |
Why?
|
Endoscopy | 1 | 2017 | 1849 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23712 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 2911 | 0.020 |
Why?
|
Hospital Bed Capacity, 100 to 299 | 1 | 2007 | 11 | 0.020 |
Why?
|
Patient Access to Records | 1 | 2008 | 119 | 0.020 |
Why?
|
Hospital Bed Capacity, 500 and over | 2 | 1997 | 114 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5790 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 2137 | 0.020 |
Why?
|
Cell Cycle | 1 | 2015 | 2929 | 0.020 |
Why?
|
Capital Expenditures | 1 | 2006 | 28 | 0.020 |
Why?
|
SEER Program | 1 | 2011 | 1449 | 0.020 |
Why?
|
Colorado | 1 | 2006 | 165 | 0.020 |
Why?
|
Anticonvulsants | 1 | 1995 | 1903 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2018 | 3066 | 0.020 |
Why?
|
Protein Binding | 1 | 2017 | 9340 | 0.010 |
Why?
|
Recurrence | 1 | 2017 | 8466 | 0.010 |
Why?
|
Phagocytes | 1 | 2006 | 296 | 0.010 |
Why?
|
Budgets | 1 | 2006 | 229 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2003 | 6388 | 0.010 |
Why?
|
Medical Records | 1 | 2008 | 1407 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10759 | 0.010 |
Why?
|
Delphi Technique | 1 | 2006 | 835 | 0.010 |
Why?
|
Leukemia P388 | 1 | 2001 | 14 | 0.010 |
Why?
|
Templates, Genetic | 1 | 2001 | 189 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9410 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8519 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6475 | 0.010 |
Why?
|
Drug Utilization | 1 | 2006 | 1188 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2006 | 2683 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16945 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18216 | 0.010 |
Why?
|
Survivors | 1 | 2008 | 2369 | 0.010 |
Why?
|
Erythrocytes | 1 | 2006 | 2417 | 0.010 |
Why?
|
Enzyme Multiplied Immunoassay Technique | 1 | 1995 | 7 | 0.010 |
Why?
|
Laboratories, Hospital | 1 | 1997 | 192 | 0.010 |
Why?
|
Plant Extracts | 1 | 1999 | 497 | 0.010 |
Why?
|
Hypertension | 1 | 2015 | 8527 | 0.010 |
Why?
|
Phenytoin | 1 | 1995 | 189 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 1997 | 343 | 0.010 |
Why?
|
Phenobarbital | 1 | 1995 | 191 | 0.010 |
Why?
|
Carbamazepine | 1 | 1995 | 224 | 0.010 |
Why?
|
Molecular Structure | 1 | 1999 | 1875 | 0.010 |
Why?
|
Mice | 2 | 2017 | 81402 | 0.010 |
Why?
|
Radiology Department, Hospital | 1 | 1997 | 406 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 1997 | 601 | 0.010 |
Why?
|
Valproic Acid | 1 | 1995 | 442 | 0.010 |
Why?
|
Chick Embryo | 1 | 1994 | 982 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 1994 | 794 | 0.010 |
Why?
|
Models, Molecular | 1 | 2001 | 5427 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1997 | 1459 | 0.010 |
Why?
|
Observer Variation | 1 | 1995 | 2604 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1994 | 3075 | 0.000 |
Why?
|
Staphylococcal Infections | 1 | 1997 | 1409 | 0.000 |
Why?
|
Heart | 1 | 1994 | 4391 | 0.000 |
Why?
|